- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacological management of polycystic kidney disease
Authors
Keywords
-
Journal
EXPERT OPINION ON PHARMACOTHERAPY
Volume 15, Issue 8, Pages 1085-1095
Publisher
Informa Healthcare
Online
2014-03-29
DOI
10.1517/14656566.2014.903923
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bosutinib
- (2014) Lindsay Stansfield et al. ANNALS OF PHARMACOTHERAPY
- Clinical Characteristics and Disease Predictors of a Large Chinese Cohort of Patients with Autosomal Dominant Polycystic Kidney Disease
- (2014) Dongping Chen et al. PLoS One
- Rationale and Design of the DIPAK 1 Study: A Randomized Controlled Clinical Trial Assessing the Efficacy of Lanreotide to Halt Disease Progression in Autosomal Dominant Polycystic Kidney Disease
- (2013) Esther Meijer et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Cost-Effectiveness of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease
- (2013) Kevin F. Erickson et al. ANNALS OF INTERNAL MEDICINE
- Effect of percutaneous renal denervation on blood pressure level and sympathetic activity in a patient with polycystic kidney disease
- (2013) Aleksander Prejbisz et al. Clinical Research in Cardiology
- Type of PKD1 Mutation Influences Renal Outcome in ADPKD
- (2013) E. Cornec-Le Gall et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Strategies Targeting cAMP Signaling in the Treatment of Polycystic Kidney Disease
- (2013) V. E. Torres et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Short-term renal hemodynamic effects of tolvaptan in subjects with autosomal dominant polycystic kidney disease at various stages of chronic kidney disease
- (2013) Wendy E. Boertien et al. KIDNEY INTERNATIONAL
- Therapeutic use of traditional Chinese herbal medications for chronic kidney diseases
- (2013) Yifei Zhong et al. KIDNEY INTERNATIONAL
- Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial
- (2013) Anna Caroli et al. LANCET
- Prevalence of Cardiovascular Events in Patients with Autosomal Dominant Polycystic Kidney Disease
- (2012) Imed Helal et al. AMERICAN JOURNAL OF NEPHROLOGY
- Efficacy and Safety of mTOR Inhibitor Therapy in Patients With Early-Stage Autosomal Dominant Polycystic Kidney Disease: A Meta-Analysis of Randomized Controlled Trials
- (2012) Qiang He et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Autosomal dominant polycystic kidney disease: recent advances in pathogenesis and potential therapies
- (2012) Toshio Mochizuki et al. Clinical and Experimental Nephrology
- Kidney Volume and Functional Outcomes in Autosomal Dominant Polycystic Kidney Disease
- (2012) A. B. Chapman et al. Clinical Journal of the American Society of Nephrology
- Polycystic kidney disease
- (2012) Theodore I. Steinman CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Percutaneous transluminal renal denervation: A potential treatment option for polycystic kidney disease-related pain?
- (2012) Sharad V. Shetty et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Rapamycin for treatment of type I autosomal dominant polycystic kidney disease (RAPYD-study): a randomized, controlled study
- (2012) G. Stallone et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Somatostatin analog therapy for severe polycystic liver disease: results after 2 years
- (2012) M. C. Hogan et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Aquaretic Treatment in Polycystic Kidney Disease
- (2012) Rudolf P. Wüthrich et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
- (2012) Vicente E. Torres et al. NEW ENGLAND JOURNAL OF MEDICINE
- The long-term outcome of patients with polycystic liver disease treated with lanreotide
- (2011) M. Chrispijn et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Intermediate Volume on Computed Tomography Imaging Defines a Fibrotic Compartment that Predicts Glomerular Filtration Rate Decline in Autosomal Dominant Polycystic Kidney Disease Patients
- (2011) Anna Caroli et al. AMERICAN JOURNAL OF PATHOLOGY
- c-Src inactivation reduces renal epithelial cell-matrix adhesion, proliferation, and cyst formation
- (2011) Justine Elliott et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Phase II study of single-agent bosutinib, a Src/Abl tyrosine kinase inhibitor, in patients with locally advanced or metastatic breast cancer pretreated with chemotherapy
- (2011) M. Campone et al. ANNALS OF ONCOLOGY
- Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: Three Years' Experience
- (2011) E. Higashihara et al. Clinical Journal of the American Society of Nephrology
- Potential Deleterious Effects of Vasopressin in Chronic Kidney Disease and Particularly Autosomal Dominant Polycystic Kidney Disease
- (2011) E. Meijer et al. KIDNEY & BLOOD PRESSURE RESEARCH
- Short-term effects of tolvaptan on renal function and volume in patients with autosomal dominant polycystic kidney disease
- (2011) Maria V. Irazabal et al. KIDNEY INTERNATIONAL
- Analysis of baseline parameters in the HALT polycystic kidney disease trials
- (2011) Vicente E. Torres et al. KIDNEY INTERNATIONAL
- Therapeutic potential of vasopressin V2 receptor antagonist in a mouse model for autosomal dominant polycystic kidney disease: optimal timing and dosing of the drug
- (2011) E. Meijer et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Mechanism-Based Therapeutics for Autosomal Dominant Polycystic Kidney Disease: Recent Progress and Future Prospects
- (2011) Ming-Yang Chang et al. NEPHRON CLINICAL PRACTICE
- Extrarenal Manifestations of Autosomal Dominant Polycystic Kidney Disease
- (2010) Yves Pirson ADVANCES IN CHRONIC KIDNEY DISEASE
- Treatment Strategies and Clinical Trial Design in ADPKD
- (2010) Vicente E. Torres ADVANCES IN CHRONIC KIDNEY DISEASE
- Therapeutic mTOR Inhibition in Autosomal Dominant Polycystic Kidney Disease: What Is the Appropriate Serum Level?
- (2010) G. Canaud et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Prospects for mTOR Inhibitor Use in Patients with Polycystic Kidney Disease and Hamartomatous Diseases
- (2010) V. E. Torres et al. Clinical Journal of the American Society of Nephrology
- Reducing Polycystic Liver Volume in ADPKD: Effects of Somatostatin Analogue Octreotide
- (2010) A. Caroli et al. Clinical Journal of the American Society of Nephrology
- The HALT Polycystic Kidney Disease Trials: Design and Implementation
- (2010) A. B. Chapman et al. Clinical Journal of the American Society of Nephrology
- Renal Function and Healthcare Costs in Patients with Polycystic Kidney Disease
- (2010) K. L. Lentine et al. Clinical Journal of the American Society of Nephrology
- Potentially Modifiable Factors Affecting the Progression of Autosomal Dominant Polycystic Kidney Disease
- (2010) V. E. Torres et al. Clinical Journal of the American Society of Nephrology
- Randomized Clinical Trial of Long-Acting Somatostatin for Autosomal Dominant Polycystic Kidney and Liver Disease
- (2010) M. C. Hogan et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Sirolimus Therapy to Halt the Progression of ADPKD
- (2010) N. Perico et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Sirolimus attenuates disease progression in an orthologous mouse model of human autosomal dominant polycystic kidney disease
- (2010) Iram Zafar et al. KIDNEY INTERNATIONAL
- Imaging for the prognosis of autosomal dominant polycystic kidney disease
- (2010) Kyongtae T. Bae et al. Nature Reviews Nephrology
- Triptolide reduces cyst formation in a neonatal to adult transition Pkd1 model of ADPKD
- (2010) S. J. Leuenroth et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Sirolimus and Kidney Growth in Autosomal Dominant Polycystic Kidney Disease
- (2010) Andreas L. Serra et al. NEW ENGLAND JOURNAL OF MEDICINE
- Everolimus in Patients with Autosomal Dominant Polycystic Kidney Disease
- (2010) Gerd Walz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Screening for Intracranial Aneurysm in 355 Patients With Autosomal-Dominant Polycystic Kidney Disease
- (2010) H.W. Xu et al. STROKE
- MRI-based Kidney Volume Measurements in ADPKD: Reliability and Effect of Gadolinium Enhancement
- (2009) K. T. Bae et al. Clinical Journal of the American Society of Nephrology
- A Case for Water in the Treatment of Polycystic Kidney Disease
- (2009) V. E. Torres et al. Clinical Journal of the American Society of Nephrology
- Lanreotide Reduces the Volume of Polycystic Liver: A Randomized, Double-Blind, Placebo-Controlled Trial
- (2009) Loes van Keimpema et al. GASTROENTEROLOGY
- Renal Volume, Renin-Angiotensin-Aldosterone System, Hypertension, and Left Ventricular Hypertrophy in Patients with Autosomal Dominant Polycystic Kidney Disease
- (2009) R. W. Schrier JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Autosomal dominant polycystic kidney disease: the last 3 years
- (2009) Vicente E. Torres et al. KIDNEY INTERNATIONAL
- Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease
- (2009) Tevfik Ecder et al. Nature Reviews Nephrology
- Long-term rapamycin therapy in the Han:SPRD rat model of polycystic kidney disease (PKD)
- (2009) I. Zafar et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Polycystic Kidney Disease
- (2008) Peter C. Harris et al. Annual Review of Medicine
- Contribution of Renal Innervation to Hypertension in Rat Autosomal Dominant Polycystic Kidney Disease
- (2008) Vincent H. Gattone et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Src Inhibition Ameliorates Polycystic Kidney Disease
- (2008) W. E. Sweeney et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Triptolide Reduces Cystogenesis in a Model of ADPKD
- (2008) S. J. Leuenroth et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Increases in kidney volume in autosomal dominant polycystic kidney disease can be detected within 6 months
- (2008) Andreas D. Kistler et al. KIDNEY INTERNATIONAL
- Autosomal Dominant Polycystic Kidney Disease
- (2008) Jared J. Grantham NEW ENGLAND JOURNAL OF MEDICINE
- Autosomal Dominant Polycystic Kidney Disease: Recent Advances in Pathogenesis and Treatment
- (2007) Ming-Yang Chang et al. NEPHRON PHYSIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started